Dickinson Andrew Dinsider trades
In SEC Form 4 filings, Dickinson Andrew D is listed as Chief Financial Officer of Gilead Sciences, Inc. (GILD). In the last 90 days, Dickinson Andrew D sold $904.5K of Gilead Sciences, Inc. (GILD) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| GILDGilead Sciences, Inc. | Chief Financial Officer | 5 | Oct 16 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-11
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| GILDGilead Sciences, Inc. | Oct 15 | Oct 16 | S | 3,000 | $156.22 | Sale −$468,660 | 161,096 | Yes | Form 4 |
| GILDGilead Sciences, Inc. | Sep 15 | Sep 16 | S | 3,000 | $145.29 | Sale −$435,870 | 164,096 | Yes | Form 4 |
| GILDGilead Sciences, Inc. | Sep 10 | Sep 11 | M | 2,797 | not reported | not reported | 168,443 | No | Form 4 |
| GILDGilead Sciences, Inc. | Sep 10 | Sep 11 | F | 1,347 | $144.81 | $195,059 | 167,096 | No | Form 4 |
| GILDGilead Sciences, Inc. | Sep 10 | Sep 11 | M · derivative | 2,797 | not reported | not reported | 25,054 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.